The market size of the domestic pharmaceutical packaging industry has exceeded 100 billion, and the future growth is high

【Pharmaceutical Network Market Analysis】Pharmaceutical packaging is one of the important carriers of drugs, mainly including paper packaging, glass packaging, rubber packaging and metal packaging and other types
.
In recent years, with the continuous development of the domestic pharmaceutical market, the pharmaceutical packaging industry has also grown rapidly, and the market size has exceeded 100 billion yuan
.
The market size of the domestic pharmaceutical packaging industry has exceeded 100 billion, and the future growth is high (Image source: Pharmaceutical Network) At present, China's pharmaceutical manufacturing industry is developing strongly, injecting growth momentum
into the domestic pharmaceutical packaging industry.
Taking the ophthalmic field as an example, China's ophthalmic diseases are diverse, the patient base is large, and the demand for ophthalmic drugs and ophthalmic medical devices is broad, which will drive the market scale of the upstream ophthalmic packaging industry to grow
。 According to Frost & Sullivan's forecast, the market size of China's ophthalmic medical devices will reach 28.
3 billion yuan in 2025 and 49.
2 billion yuan in 2030, corresponding to a CAGR of 17.
0% from 2020 to 2025; The market size of ophthalmic therapeutic drugs was 18.
8 billion yuan in 2020, and is expected to reach 44 billion yuan in 2025 and 108.
4 billion yuan in 2030, corresponding to a CAGR of 18.
5%
from 2020 to 2025.
With the aging of the population and the diversification of the types of pharmaceutical products in the future, its upstream pharmaceutical packaging industry will have high growth
.
At the same time, under the background of the standardized development of the pharmaceutical industry, the safety of medication is constantly improving, the pharmaceutical packaging industry will also face higher requirements, and the industry will accelerate transformation and upgrading
.
For example, in the field of pharmaceutical glass, at present, China is still dominated by soda-lime glass and low borosilicate glass, with the promotion of policies such as consistency evaluation, the safety requirements of the pharmaceutical industry continue to improve, and it is expected that the proportion of domestic borosilicate glass will continue to increase in the future, and the market space is huge
.
However, at present, the overall concentration of the domestic pharmaceutical packaging industry is not high, the market is mostly monopolized by foreign-funded enterprises, with the continuous efforts of domestic enterprises, pharmaceutical packaging import substitution space is worth looking forward to
.
At present, many companies are accelerating domestic substitution and international layout
in the pharmaceutical packaging business.
For example, Dongfeng mentioned in the investor relations activity record table released on October 20 that in the first half of 2022, the company's pharmaceutical packaging business achieved sales revenue of RMB 278 million, a year-on-year increase of 7.
21%.

In terms of customer expansion, in the first half of 2022, the company's pharmaceutical packaging segment has both domestic customers and foreign pharmaceutical customers, and the customer structure continues to be optimized
.
Relatively speaking, foreign pharmaceutical companies have relatively high requirements for packaging, and correspondingly there will be more profit margins, and the company's entire pharmaceutical package sector is expected to rise in volume and price in the future, and the gross profit margin should be further optimized
.
In March this year, Huaqiang Technology explained the reasons for the company's performance growth in 2021, saying that the company's pharmaceutical packaging and collective protection business continued to improve, driving the company's overall revenue to grow
significantly.
It is reported that the company is continuing to develop the pharmaceutical packaging and medical device business, and has previously promoted the domestic replacement of pharmaceutical rubber stoppers, and launched highly compatible pharmaceutical diaphragm rubber stoppers to achieve domestic substitution
.
As far as the future development direction of the pharmaceutical packaging industry is concerned, domestic pharmaceutical packaging will gradually transform from the past drug excessive packaging to "low-carbon" packaging
.
In September this year, China's first "Guidelines for the Reduction of Pharmaceutical Packaging Tablets and Capsules" group standard was officially released, this time the standard focuses on the collection of tablets and capsules, and puts forward relevant provisions
from the aspects of packaging void rate, number of packaging layers, material selection, medium packaging, transport packaging, etc.
After the release of this standard, the industry generally believes that the road of simplifying the complexity of China's pharmaceutical packaging is about to open
.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.